跳至主要内容
临床试验/2024-517384-24-00
2024-517384-24-00招募中2 期

INNOVATIVE TREATMENT OF SCARRED VOCAL FOLDS BY LOCAL INJECTION OF AUTOLOGOUS ADIPOSE-DERIVED STROMAL VASCULAR FRACTION: EFFICACY VERSUS PLACEBO

Centre Hospitalier Regional De Marseille2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2024年9月30日最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
36
试验地点
2
主要终点
Changes from baseline in Self-evaluation with the Voice Handicap Index (VHI), a shift in the total score of 18 points or greater being required to be clinically significant (Jacobson, 1997)

研究概览

简要总结

Evaluate and compare the efficacy of fresh autologous adipose-derived stromal vascular fraction injection, in comparison with a placebo (saline solution and human serum albumin, vehicle of SVF without cells), on dysphonia linked to scarred vocal cords, based on a self-assessment via the Voice Handicap Index (significant improvement if ≥ 18 points according to Jacobson) at 6 months post treatment.

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • Subscription to the French Social Security System
  • Voice Handicap Index > 50/120
  • Scarred vocal folds, congenital (sulcus) or after phonosurgery
  • Scarred middle third in videolaryngostroboscopy
  • At least six-months delay after initial surgery if appropriate
  • Patients aged between 18 and 70
  • Good general condition
  • Negative pregnancy test & contraception for women of child-bearing age

排除标准

  • Refusal of speech therapy
  • BMI < 18 kg/m2 to insure adequate abdominal or other subcutaneous adipose tissue accessible to lipoharvest
  • History of malignant lesion or severe dysplasia of the scarred vocal fold
  • History of laryngeal papillomatosis
  • Contre-indication à l'anesthésie locale
  • Anti-coagulant treatment
  • Coagulation disorders (Prothrombin Ratio <65%, Activated Partial Thromboplastin Time >1,2)
  • Active infectious diseases
  • Any active viral infection from among the following: HIV, HTLV I and II, VHB, VHC and Syphilis
  • Known sensitivity to human serum albumin (HSA)

结局指标

主要结局

Changes from baseline in Self-evaluation with the Voice Handicap Index (VHI), a shift in the total score of 18 points or greater being required to be clinically significant (Jacobson, 1997)

Changes from baseline in Self-evaluation with the Voice Handicap Index (VHI), a shift in the total score of 18 points or greater being required to be clinically significant (Jacobson, 1997)

次要结局

  • VHI at 1 month
  • self-evaluation of dysphonia (0-10 scale)
  • voice acoustic measurements
  • voice aerodynamic measurements: maximum phonation time
  • perceptive analysis (GRB scale): score will be calculated by addition of two characteristics
  • videolaryngostroboscopy
  • The incidence of related Adverse Events

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Alexia Mattei

Scientific

Centre Hospitalier Regional De Marseille

研究点 (2)

Loading locations...

相似试验